UPSC Prelims Practice Questions — PARLIAMENT QUESTION: BIOE3 POLICY

Q1. Under the BioE3 Policy, the joint Calls for Proposals spanning the six thematic sectors are issued by the Department of Biotechnology together with which one of the following?

  • A. Biotechnology Industry Research Assistance Council (BIRAC)
  • B. National Research Development Corporation (NRDC)
  • C. Centre for Cellular and Molecular Platforms (C-CAMP)
  • D. Technology Development Board (TDB)

Q2. How many strategic/thematic sectors does the BioE3 Policy prioritise for high-performance biomanufacturing?

  • A. Four
  • B. Five
  • C. Six
  • D. Eight

Q3. Under whose chairmanship did the Union Cabinet approve the BioE3 Policy that mandates the setting up of Biofoundries, Biomanufacturing Hubs and Bio-AI Hubs?

  • A. Prime Minister Narendra Modi
  • B. Union Minister of Science & Technology Dr. Jitendra Singh
  • C. The Principal Scientific Adviser to the Government of India
  • D. The Vice-Chairman of NITI Aayog

Q4. As per the projected break-up of India's targeted USD 300 billion bioeconomy by 2030, which one of the following is expected to be the single largest subsector?

  • A. BioMedical
  • B. BioIndustrial
  • C. BioServices
  • D. BioAgriculture

Q5. As cited in 2025 government data, India's bioeconomy was valued at approximately USD 165.7 billion in which year?

  • A. 2022
  • B. 2023
  • C. 2024
  • D. 2025

Q6. Among the six thematic sectors of the BioE3 Policy, how many are named specifically for climate/environmental functions, namely 'Carbon Capture & Utilization' and 'Climate-Resilient Agriculture'?

  • A. One
  • B. Two
  • C. Three
  • D. Four

Q7. In the context of recent BioE3 implementation, the term 'Mūlānkur' refers to which one of the following?

  • A. The umbrella brand for the DBT-BIRAC BioEnablers (Biofoundries, Biomanufacturing Hubs and Bio-AI Hubs) being established under BioE3
  • B. A flagship smart-protein product line developed for India's functional-foods market
  • C. A national registry of carbon credits generated by biomanufacturing units
  • D. A gene-therapy clinical trial network funded exclusively by BIRAC